Trial Profile
Effects of Different Anti-Rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Antirheumatics
- Indications Pneumococcal infections; Rheumatic disorders; Rheumatoid arthritis
- Focus Pharmacodynamics
- Acronyms PVA
- 02 Oct 2018 Status changed from active, no longer recruiting to completed.
- 14 Sep 2017 Planned End Date changed from 1 Dec 2013 to 1 Dec 2018.
- 14 Sep 2017 Planned primary completion date changed from 1 Dec 2013 to 1 Dec 2018.